These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1834657)
21. Beta-very low density lipoprotein uptake in cultured fibroblasts and smooth muscle cells from Watanabe heritable hyperlipidemic rabbits. Wernette-Hammond ME; Garcia Z; Arnold KS; Innerarity TL Arteriosclerosis; 1989; 9(4):501-10. PubMed ID: 2546526 [TBL] [Abstract][Full Text] [Related]
22. Electron-microscopic and hydrodynamic characterization of recombinant apolipoprotein (a) and its association with LDL. Phillips ML; Lembertas AV; Schumaker VN; Lawn RM; Shire SJ; Zioncheck TF Chem Phys Lipids; 1994 Jan; 67-68():91-7. PubMed ID: 8187249 [TBL] [Abstract][Full Text] [Related]
23. Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2. Tam SP; Zhang X; Koschinsky ML J Lipid Res; 1996 Mar; 37(3):518-33. PubMed ID: 8728315 [TBL] [Abstract][Full Text] [Related]
24. Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages. Snyder ML; Polacek D; Scanu AM; Fless GM J Biol Chem; 1992 Jan; 267(1):339-46. PubMed ID: 1530930 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. Hofmann SL; Eaton DL; Brown MS; McConathy WJ; Goldstein JL; Hammer RE J Clin Invest; 1990 May; 85(5):1542-7. PubMed ID: 2139667 [TBL] [Abstract][Full Text] [Related]
26. Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). Armstrong VW; Walli AK; Seidel D J Lipid Res; 1985 Nov; 26(11):1314-23. PubMed ID: 2999280 [TBL] [Abstract][Full Text] [Related]
27. Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. Krempler F; Kostner GM; Roscher A; Haslauer F; Bolzano K; Sandhofer F J Clin Invest; 1983 May; 71(5):1431-41. PubMed ID: 6304146 [TBL] [Abstract][Full Text] [Related]
28. Functional unit of the low density lipoprotein receptor of fibroblasts: a 100,000-dalton structure with multiple binding sites. Innerarity TL; Kempner ES; Hui DY; Mahley RW Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4378-82. PubMed ID: 6270675 [TBL] [Abstract][Full Text] [Related]
29. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Caplice NM; Panetta C; Peterson TE; Kleppe LS; Mueske CS; Kostner GM; Broze GJ; Simari RD Blood; 2001 Nov; 98(10):2980-7. PubMed ID: 11698280 [TBL] [Abstract][Full Text] [Related]
30. The relationship between lipoprotein(a) and low density lipoprotein receptors during the treatment of hyperthyroidism. Hayashi H; Mizushima N; Yoshinaga H; Kawamitsu H; Matsuda S; Tanoue M; Kurosawa H; Fujimoto H; Amakawa T Horm Metab Res; 1996 Aug; 28(8):384-7. PubMed ID: 8886825 [TBL] [Abstract][Full Text] [Related]
32. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Pitas RE; Innerarity TL; Weinstein JN; Mahley RW Arteriosclerosis; 1981; 1(3):177-85. PubMed ID: 6895305 [TBL] [Abstract][Full Text] [Related]
33. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533 [TBL] [Abstract][Full Text] [Related]
34. Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts. Havekes L; Vermeer BJ; Brugman T; Emeis J FEBS Lett; 1981 Sep; 132(2):169-73. PubMed ID: 6271586 [No Abstract] [Full Text] [Related]
35. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity. Galeano NF; Al-Haideri M; Keyserman F; Rumsey SC; Deckelbaum RJ J Lipid Res; 1998 Jun; 39(6):1263-73. PubMed ID: 9643358 [TBL] [Abstract][Full Text] [Related]
36. Receptor binding activity of high-density lipoproteins containing apoprotein E from abetalipoproteinemic and normal neonate plasma. Innerarity TL; Bersot TP; Arnold KS; Weisgraber KH; Davis PA; Forte TM; Mahley RW Metabolism; 1984 Feb; 33(2):186-95. PubMed ID: 6319954 [TBL] [Abstract][Full Text] [Related]
37. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Datta G; Chaddha M; Garber DW; Chung BH; Tytler EM; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM Biochemistry; 2000 Jan; 39(1):213-20. PubMed ID: 10625496 [TBL] [Abstract][Full Text] [Related]
38. Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype. Guo HC; Chapman MJ; Bruckert E; Farriaux JP; De Gennes JL Atherosclerosis; 1991 Jan; 86(1):69-83. PubMed ID: 1829609 [TBL] [Abstract][Full Text] [Related]
40. Interaction of lipoprotein Lp(a) and low density lipoprotein with glycosaminoglycans from human aorta. Bihari-Varga M; Gruber E; Rotheneder M; Zechner R; Kostner GM Arteriosclerosis; 1988; 8(6):851-7. PubMed ID: 2973783 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]